Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Sage Therapeutic Com (SAGE)

71.51   0.69 (0.97%) 10-24 14:04
Open: 71.17 Pre. Close: 70.82
High: 72.1 Low: 70.335
Volume: 368,479 Market Cap: 3,717M
SAGE Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel medicines to treat life-altering central nervous system. The company is headquartered in Cambridge, Massachusetts and currently employs 637 full-time employees. The firm is engaged in developing and commercializing medicines to treat central nervous system (CNS) disorders. The firm's lead product candidate, SAGE-547 is an intravenous formulation of allopregnanolone, a neurosteroid that acts as a synaptic and extrasynaptic modulator of the Gamma-Amino Butyric Acid-A (GABAA) receptor. The firm's next-generation product candidates, SAGE-217 and SAGE-689, also target the GABAA receptor system. The firm is focused on developing drugs based on selective allosteric modulation of CNS synaptic and extrasynaptic receptors. The firm's chemistry platform is focused on the chemical scaffolds of endogenous or chemically modified synthetic neuroactive steroid compounds that are allosteric modulators of GABAA or N-Methyl-D-aspartic acid or N-Methyl-D-aspartate (NMDA) receptors.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 72.189 - 72.456 72.456 - 72.672
Low: 69.608 - 69.945 69.945 - 70.215
Close: 71.002 - 71.524 71.524 - 71.944

Technical analysis

as of: 2020-10-23 4:48:40 PM
Overall:       
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 84.39     One year: 98.57
Support: Support1: 63.26    Support2: 57.71
Resistance: Resistance1: 72.25    Resistance2: 84.39
Pivot: 66.40
Moving Average: MA(5): 69.87     MA(20): 64.73
MA(100): 50.99     MA(250): 61.17
MACD: MACD(12,26): 3.44     Signal(9): 3.08
Stochastic oscillator: %K(14,3): 83.50     %D(3): 80.50
RSI: RSI(14): 66.60
52-week: High: 155.33  Low: 25.01  Change(%): -49.7
Average Vol(K): 3-Month: 67142  10-Days: 67882

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
SAGE has closed below upper band by 11.3%. Bollinger Bands are 54.9% wider than normal. The large width of the bands suggest high volatility as compared to SAGE's normal range. The bands have been in this wide range for 5 bars. This is a sign that the current trend might continue.

Headline News

Fri, 16 Oct 2020
Ladenburg Thalmann & Co. Stick to Their Hold Rating for SAGE Therapeutics - Investing.com

Fri, 16 Oct 2020
Canaccord Genuity Stick to Their Buy Rating for SAGE Therapeutics - Investing.com

Thu, 15 Oct 2020
Sage shares data on retreatment with depression drug zuranolone - FierceBiotech

Wed, 30 Sep 2020
Active adult community Sage Plum Creek coming to Kyle - Community Impact Newspaper

Mon, 10 Aug 2020
Sage Therapeutics Announces Second Quarter 2020 Financial Results and Highlights Pipeline and Business Progress - Business Wire

Thu, 25 Jun 2020
Is Sage Therapeutics a Buy? - The Motley Fool

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 52
Shares Float (M) 51
% Held by Insiders 1.83
% Held by Institutions 109.71
Shares Short (K) 7,260
Shares Short P. Month (K) 7,270

Stock Financials

EPS -11.800
EPS Est This Year -7.400
EPS Est Next Year -7.690
Book Value (p.s.) 14.250
Profit Margin
Operating Margin -6782.76
Return on Assets (ttm) -35.2
Return on Equity (ttm) -63.0
Qtrly Rev. Growth 24.7
Gross Profit (p.s.) -6.972
Sales Per Share 0.171
EBITDA (p.s.) -11.570
Qtrly Earnings Growth
Operating Cash Flow (M) -501
Levered Free Cash Flow (M) -266

Stock Valuations

PE Ratio -6.06
PEG Ratio
Price to Book value 5.02
Price to Sales 417.57
Price to Cash Flow -7.42

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.